ERBB2 and breast carcinoma: When taking breast cancer subtypes into account, we found that IDO1 was highly expressed in ER‐negative, PR‐negative and Her2‐negative samples (Figure 1B) and basal‐like breast cancer than other types breast cancers (Figure 1C).